either significantly more male zygotes are produced at fertilization and that losses before implantation are randomly distributed between the two sexes, or that similar numbers of male and female zygotes are formed but that more female blastocysts fail to become implanted.
Investigations of the sex chromatin or chromosomes of unimplanted blastocysts suggest that immediately before implantation there are equal numbers of male and female blastocysts in the mouse (49 males, 49 females: Vickers 1967) , in the pig (38 males, 39 females: McFeely 1967) and in the rabbit (28 males, 27 females: Melander 1962) but, surprisingly, not in the hamster (63 males, 35 females: Sundell 1962). It would seem, then, that selection occurs at implantation and the male Y-linked-antigen-bearing blastocysts are preferentially implanted.
Further support for this hypothesis comes from sex ratio data in inbreeding communities. Inbreeding should tend to reduce the difference in autosomal antigens between mother and blastocyst and hence accentuate the importance of Y-linked antigens at implantation. Studies of cousin marriages (Kirby et al. 1967) show that 420 males and 343 females were borna sex ratio of 0-55. They also showed that if there had already been consanguinity within three generations of the first cousin marriage the sex ratio rose to 061. ABO blood group antigen compatibility between mother and offspring has recently been related to placental size in humans (Jones 1968 ). Presumably compatibility affects trophoblast activity. Certainly A antigen at least has been demonstrated on the surface of human trophoblast cells (Gross 1966 ). If at implantation mother and offspring are compatible on the ABO blood group system (because the mother does not possess the specific antibody) then Y-linked antigen should become more conspicuous on the blastocyst. It follows that in these groups more male blastocysts will implant with a resultant elevation of the sex ratio at birth. The data available (Allan 1959 ) support this hypothesis. AB mothers (who possess neither anti-A nor anti-B antibody) have significantly more male than female babies (sex ratio of 0 55). Similarly there is a high sex ratio of 0 babies of 0 mothers, and B babies of B mothers. A babies from A mothers, however, have a low sex ratio. This exception cannot be explained. If the babies are of blood group O (no-A or B antigens) they should have ex hypothesi a higher sex ratio quite irrespective of the blood group of the mother. Again the evidence is confirmatory (Allan 1959) .
Conclusion
The data on which these hypotheses are based are often small, inadequately controlled or awaiting confirmation.-When more investigators direct their attention to this early period of pregnancy and some of the confused issues are sorted out we shall know with more certainty whether immunological events play a role before the placenta is formed. Immunological isolation of the mammalian foetus probably plays an important role in maintaining its freedom from rejection by the mother. It is unlikely, however, that such isolation can be the sole mechanism responsible for ensuring the successful development of an allogeneic conceptus. The existence of the foeto-maternal barrier (Currie 1968 ) remains in doubt, especially in view of the disturbing and unlikely results of Tuffrey et al. (1969) .
Their demonstration of a massive exodus of maternal cells into the foetus obviously needs urgent confirmation or denial but does, however, help to underline one well-described feature of the so-called foeto-maternal barrier; i.e. it is incomplete. In man, there is a two-way traffic of cells between feetus and mother probably occurring throughout pregnancy. Venous deportation of trophoblast into the mother occurs on a massive scale (Douglas et al. 1959) . Faetal red cells can also be detected in the maternal circulation.
In other species foeto-maternal cellular leakages have been suspected but not yet adequately confirmed, except of course in the chinchilla (Billington & Weir 1967) .
What is the response of the mother to a leakage of cells from her foetus ? Does her reaction, if any, have any biological importance in maintaining the immunological integrity of her conceptus? Medawar & Sparrow (1956) showed that paternal skin grafts were rejected normally by pregnant interstrain-mated mice. This crucial experiment seemed to suggest that the mother remained in immunological ignorance throughout her pregnancy and was unaware of the foreignness of her foetus. However, Herzenberg & Gonzales (1962) and many other groups have subsequently detected specific anti-paternal hwemagglutinins in the peripheral blood of interstrain pregnant mice. Sterile matings or ingestion of the products of conception do not provoke the formation of such antibodies (Goodlin & Herzenberg 1964) . They are produced in response to conception. This means that the mother has been immunized against her feetus and yet fails to reject it. Indeed, Breyere & Barrett (1960) have shown that multiple interstrain pregnancies will prolong the survival of grafted paternal tissue.
We are therefore faced with an intriguing problem. The pregnant mouse is immunized against foetal antigens and yet does not react against them in the conventional manner. The following experiments were designed in an attempt to unravel this immunological paradox.
Experimental
These studies employed two strains of highly inbred mice. These were strains A2G and CBA which differ at the H2 locus. Female mice, usually of A2G strain, were mated overnight with either A2G or CBA males thus providing a series of dated pregnancies, either intraor inter-strain.
Pregnancy in the mouse is associated with splenomegaly. The first very simple exercise was to see whether this increase in spleen size is Pregnancy-induced splenomegaly is unaffected by the mating combination used. Intrastrain pregnant mice (A2G x A2G, continuous line) demonstrate similar degrees ofsplenomegaly to interstrain pregnantfemales (CBA x A2G, dotted lines). The results shown are the mean weights in milligrammes ± 2 standard deviations immunologically determined by foeto-maternal histoincompatibility.
Mice were killed at various stages during and after a first pregnancy and their spleens weighed. The results are shown in Fig 1. As can be seen, there is no significant difference in spleen weight between intraor inter-strain pregnant mice at any stage of pregnancy. Spleen weight is therefore of no value in assessing maternal responses and the splenomegaly is probably not related to immunological mechanisms.
We must look elsewhere for a method of assessing maternal reactions to foetal alloantigens. One possible method is to modify the technique of Breyere & Barrett (1960) and examine the growth of a paternal strain tumour when transplanted to the pregnant female mouse during a first interstrain pregnancy. Cells from a chemically induced CBA strain specific sarcoma were transplanted to pregnant females and tumour growth and rejection observed. The first group were injected on the 9th day of pregnancy and the results are shown in Fig 2. Tumour cells transplanted to intrastrain (A2G x A2G) pregnant females were rejected just as rapidly as those transplanted to virgin females. However, there was a statistically significant increase in tumour diameter when cells were administered to interstrain (CBAxA2G) pregnant mice. This experiment was then repeated by injecting a similar group on the 19th day. As can be seen from day ofpregnancy. The paternal tumour grows much larger in interstrain (CBA x A2G) pregnant females but now also grows better in intrastrain (A2G x A2G) pregnant females than in the control A2G virgins, i.e. both specific and non-specificforms ofunreactivity are now detectable which were intrastrain pregnant there was now a significant increase in tumour diameter when compared to virgin females, indicating that some form of non-specific unreactivity was supervening.
These brief experiments indicate that one can detect unreactivity to a paternal tissue graft early in a first interstrain pregnancy. At the end of pregnancy, however, there is an additional nonspecific unreactivity not dependent upon the strain of the mating male. Breyere & Barrett (1960) have referred to the specific unreactivity as 'maternal tolerance'. This is an unfortunate misnomer as it cannot be related to immunological tolerance in the classical sense. Soren (1967) has shown that the lymphoid cells of the pregnant female are immune to paternal antigens. The presence of immune cells and circulating hmmagglutinins obviously rules out immunological tolerance as the mechanism responsible for this unreactivity. Kaliss & Dagg proposed (1964) that specific maternal unresponsiveness to paternal antigens was mediated by circulating antibodies and was another example of immunological enhancementi.e. the inhibition of cellular immune mechanisms by antibody. However, they were unable adoptively to transfer this pregnancy unresponsiveness with serum. Rubenstein & Kaliss (1964) subsequently revealed that pregnancy-induced heemagglutinins have a very short half life after adoptive transfer.
The next experiment was an attempt to transfer this unresponsiveness with pregnancy serum by giving repreated injections. The serum was obtained from intra-and inter-strain pregnant females on Day 18. A2G virgin females were injected with the CBA tumour at Day 0 and were given intraperitoneal injections of the appropriate serum on alternate days.
The results are shown in Fig 4, and indicate that the repeated injections of serum from interstrain pregnant females cause a dramatic increase in mean diameter of the paternally-derived tumour. Serum from intrastrain pregnant animals also causes a minor increase in tumour diameter. A2G virgin serum had no effect on tumour growth. Thus specific maternal unreactivity to a paternal graft can be adoptively transferred with serum.
Tumour growth in A2G virgin females was not significantly altered by interstrain pregnancy serum when the mating combination was reversed (i.e. A2G x CBA). Therefore the unresponsiveness of the pregnant female to this tumour is determined specifically by the strain of the mating male and is not related to out-crossed mating per se. It can be adoptively transferred with serum and this suggests that immunological enhancement is the mechanism underlying pregnancyinduced specific unresponsiveness to paternal antigens.
Discussion
This enhancement is a specific response to feetal antigens and is induced by conception.Which feetal (Billingham & Silvers 1965) . Histocompatibility antigens are apparently absent from the red cell, although red cells will induce specific hmmagglutinin formation and recent work by Cruse (1968) has shown that pure red cell suspensions will induce enhancement of a subsequent tumour allograft. This implies that red cells do possess histocompatibility antigens but with modified or defective immunogenicity, although retaining their specificity. It is tempting to suggest that leakage of ftetal red cells into the maternal circulation leads to the formation ofprotective antibodies which enhance the foetal allograft. However, Kirby (1968) has recently shown that repeated inoculations of allogenic murine blastocysts will lead to a specific unreactive state as shown by prolonged survival of subsequent skin grafts. It is unlikely that any red cells were inoculated in his studies. I would therefore like to postulate that the defective immunogenicity of early murine trophoblast, the subject of much recent attention, is similar to that of the red cell and that, despite its failure to induce transplantation immunity, trophoblast is responsible for the induction of specific enhancing antibodies and that the immunogenic deficit of histocompatibility antigens shared by trophoblast and the red cell may be related to the high concentration of sialic acid present in the periphery of both these cell types (Currie & Bagshawe 1968 ).
Summary
The mammalian conceptus is an allograft, cells of which probably gain access to the maternal circulation. In the mouse the mother is sensitized by this infusion of foetal cells, sensitized to histocompatibility antigens of paternal orgin. Such sensitization results in immunological enhancement of paternal tumour grafts rather than their destruction. This type of response is probably related to the defective immunogenicity of the sensitizing cells and would tend to protect the foetus rather than harm it. In a first pregnancy, this enhancement is not a powerful effect and cannot explain the failure of rejection of the conceptus as an allograft. We are therefore obliged to cling to the feetal-maternal barrier hypothesis for a little longer. However, the ability to disarm the immune response in this specific manner provides an excellent mechanism for dealing with any cellular leakages across the immunological frontier between the mother and her conceptus.
